GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Additional Paid-In Capital

NFL Biosciences (XPAR:ALNFL) Additional Paid-In Capital : €7.27 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Additional Paid-In Capital?


NFL Biosciences's quarterly additional paid-in capital increased from Dec. 2022 (€4.11 Mil) to Jun. 2023 (€7.21 Mil) and increased from Jun. 2023 (€7.21 Mil) to Dec. 2023 (€7.27 Mil).

NFL Biosciences's annual additional paid-in capital stayed the same from Dec. 2021 (€4.11 Mil) to Dec. 2022 (€4.11 Mil) but then increased from Dec. 2022 (€4.11 Mil) to Dec. 2023 (€7.27 Mil).


NFL Biosciences Additional Paid-In Capital Historical Data

The historical data trend for NFL Biosciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Additional Paid-In Capital Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 1.85 1.85 4.11 4.11 7.27

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial 4.11 4.11 4.11 7.21 7.27

NFL Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

NFL Biosciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences (XPAR:ALNFL) Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines